The Food and Drug Administration (FDA), National Institutes of Health, National Institute for Environmental Health Sciences (NIEHS) and National Center for Advancing Translational Science (NCATS), Environmental Protection Agency (EPA), Johns Hopkins School of Public Health Center for Alternatives to Animal Testing (CAAT) and the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) are collaborating to present a workshop titled Developing Microphysiological Systems for Use as Regulatory Tools- Challenges and Opportunities on May 10, 2013.
Scientists are developing microsystems using human cells to test the effects of drugs or other substances, and these systems would improve toxicity testing beyond currently available tools. This innovation in toxicology testing is important to the development of medical products so that toxicity may be identified earlier in product development, lower costs and speed new treatments to patients.
The workshop’s goal is to provide a forum for in academia, industry and regulatory agencies to address two objectives: 1) discuss essential elements needed to develop microphysiological systems as regulatory tools and 2) discuss pathways to qualification as regulatory tools.
ATTENDEES JOINING REMOTELY NEED NOT REGISTER
Remote Access Instructions:
To access the Developing Microphysiological Systems for Use as Regulatory Tools - Challenges and Opportunities lecture, follow the link provided and enter your FULL NAME in the guest entry field. The host will then allow you to enter. Audio will come from your computer speakers and closed captioning will be provided.
Access link: Microphysiological Systems Workshop
